ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2026-34664

Substance3D - Designer versions 15.1.0 and earlier are affected by an Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability that…

Published May 12, 2026 · catalog updated Aug 28, 2026 · substance 3d designer

Check if you run it

No confirmed exploitation is on record for CVE-2026-34664. EPSS is 0.29%. Act only if a listed version of substance 3d designer is installed.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Medium6.3
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.29%
Remediation
Version ranges on file
Affected products
cpe adobe/substance 3d designer · stated substance 3d designer

Substance3D - Designer versions 15.1.0 and earlier are affected by an Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability that could lead to arbitrary file system read. An attacker could exploit this vulnerability to access sensitive files and directories outside the intended access scope. Exploitation of this issue requires user interaction in that a victim must open a malicious file. Scope is changed.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • cpe adobe/substance 3d designerversion unspecified
  • stated substance 3d designer<= 15.1.0

How to fix CVE-2026-34664

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-34664. EPSS is 0.29%. Act only if a listed version of substance 3d designer is installed.

Which versions are affected?

Compare what you have installed with substance 3d designer <= 15.1.0. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-22: Path Traversal. EPSS 0.29%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. May 12, 2026 · NIST NVD

    Detected

    Substance3D - Designer versions 15.1.0 and earlier are affected by an Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability that could lead to arbitrary file system read. An attacker could exploit this vulnerability to access sensitive files and directories outside the intended access scope. Exploitation of this issue requires user interaction in that a victi

  2. Aug 28, 2026 · NIST NVD

    Updated

    Substance3D - Designer versions 15.1.0 and earlier are affected by an Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability that could lead to arbitrary file system read. An attacker could exploit this vulnerability to access sensitive files and directories outside the intended access scope. Exploitation of this issue requires user interaction in that a victi

Sources

  • CVE.orgVulnerability recordCVE-2026-34664

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-34664

    30-day exploitation probability 0.3%

    first.org
  • NIST NVDVulnerability recordCVE-2026-34664

    Substance3D - Designer versions 15.1.0 and earlier are affected by an Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability that could lead to arbitrary file system read. An attacker could exploit this vulnerability to access sensitive files

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.